Tevogen Bio Holdings Inc. Common Stock
TVGNTevogen Bio Holdings Inc. (TVGN) is a biopharmaceutical company focused on developing innovative therapies, including vaccines and treatments for infectious diseases. The company aims to leverage scientific advancements to address unmet medical needs through its research and development efforts.
Company News
Tevogen Bio explains its accumulated deficit of $129 million, highlighting that the majority represents non-cash expenses and is offset by additional paid-in capital, with total cash loss under $42 million.
The global AI in healthcare market is projected to reach nearly $700 billion by 2034, growing at 38.5% annually. Companies are developing advanced AI diagnostic technologies targeting areas like diabetic retinopathy, cardiac screening, and chronic disease management, with increasing FDA approvals and commercial potential.
